Dynavax Technologies Corp (DVAX)

[jondoeuk]

From this: ''Dr. Torrejon and his colleagues attempted to overcome the mechanisms of these resistances with combination therapy. With intratumoral administration of SD-101, a TLR-9 agonist, the JAK1/2 knockout cell lines overcame local resistance to checkpoint inhibition,even in an abscopal manner.'' https://www.targetedonc.com/conference/sitc-2018/two-rapidfire-abstracts-break-down-biomarkers-of-response-and-resistance